Life Sciences Times

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

Innoviva Specialty Therapeutics Earns Dual Nominations for 2025 Prix Galien USA Best Pharmaceutical Product Award

MSA Dallas Adopts AI-Powered Contact Center to Boost Efficiency and Patient Satisfaction

Reprieve Cardiovascular Raises $61 Million, Launches FASTR II Pivotal Trial

ZAP Surgical Marks 5,000th Patient Treated with ZAP-X Gyroscopic Radiosurgery Platform

Bionova Scientific Opens Texas Facility to Expand Plasmid DNA Production for Cell and Gene Therapy Market

Cardiosense Names Dr. John Martin as EVP and Chief Medical Officer Following FDA Clearance of CardioTag Device

OM1 Expands Neurology Network by 500,000 Patients, Boosting Real-World Evidence Capabilities

Laxxon Medical Achieves Development Milestone for Modified-Release Formulation of Veru’s Enobosarm